- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Isatuximab Carfilzomib Lenalidomide Dexamethasone
Total 487 results
-
Bristol-Myers SquibbAbbottTerminatedNewly Diagnosed, Previously Untreated Multiple MyelomaUnited States, Poland, Italy, Greece
-
Criterium, Inc.Celgene Corporation; AmgenTerminated
-
University of ChicagoGlaxoSmithKline; AmgenRecruitingMultiple Myeloma | Relapse Multiple MyelomaUnited States
-
University of Colorado, DenverNational Cancer Institute (NCI); Karyopharm Therapeutics IncRecruitingMultiple Myeloma in RelapseUnited States
-
SanofiNot yet recruiting
-
Mayo ClinicCompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
Al-Rasheed University CollegeBaghdad Medical CityWithdrawnNewly Diagnosed Multiple MyelomaIraq
-
CelgeneCompletedMultiple MyelomaUnited States
-
AbbVieRecruiting
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Canada, Australia, China, Germany, Belgium, Malaysia, Turkey, Japan, Israel, Sweden, Spain, United Kingdom, Czechia, Denmark, Brazil, Italy, France, Netherlands, Poland, Austria, Portugal, Greece, India
-
Andrew Yee, MDJanssen Research & Development, LLC; AmgenRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse | Multiple Myeloma in RelapseUnited States
-
Stichting European Myeloma NetworkFondazione EMN Italy OnlusActive, not recruiting
-
PETHEMA FoundationActive, not recruiting
-
Norwegian University of Science and TechnologyOslo University Hospital; St. Olavs HospitalCompleted
-
Dong-A University HospitalNot yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory
-
Canadian Cancer Trials GroupAmgen; Canadian Myeloma Research GroupCompleted
-
European Myeloma NetworkFondazione EMN Italy OnlusCompleted
-
OncotherapeuticsTerminated
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States, Puerto Rico
-
PfizerRecruitingMultiple MyelomaUnited States, Japan, Spain, Canada, Finland, Argentina, Norway
-
Tiziana MarangonWithdrawn
-
University of WashingtonNational Cancer Institute (NCI); SecuraBioTerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Washington University School of MedicineMillennium Pharmaceuticals, Inc.; Multiple Myeloma Research ConsortiumActive, not recruiting
-
Stanford UniversityCelgene CorporationCompletedLeukemia | AmyloidosisUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
CelgeneCompleted
-
AEterna ZentarisCompletedMultiple MyelomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); SanofiRecruitingAL AmyloidosisUnited States
-
Fondazione EMN Italy OnlusActive, not recruiting
-
Kosin University Gospel HospitalCelgeneActive, not recruitingMultiple MyelomaKorea, Republic of
-
Celgene CorporationCompletedMultiple MyelomaIreland, Spain, Australia, Austria, United Kingdom
-
Case Comprehensive Cancer CenterCompletedRefractory Multiple MyelomaUnited States
-
The First Affiliated Hospital with Nanjing Medical...UnknownDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma RefractoryChina
-
SanofiTerminatedT-cell Type Acute Leukemia-Precursor | T-lymphoblastic Lymphoma/LeukaemiaHungary, United States, Finland, France, Italy, Lithuania, Russian Federation
-
AmgenActive, not recruitingRelapsed or Refractory Multiple MyelomaUnited States, Spain, Germany, France, Italy, Denmark, Greece, Estonia
-
Gilead SciencesCompletedMultiple MyelomaUnited States, Czechia, Canada
-
PfizerCompletedAdvanced Multiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Hartford HospitalCompleted
-
CelgeneCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's Hospital; Millennium Pharmaceuticals... and other collaboratorsCompleted
-
University College, LondonCompleted
-
Criterium, Inc.AmgenCompleted
-
Wuhan Union Hospital, ChinaRecruitingMultiple Myeloma | Extramedullary Multiple Myeloma | Primary Plasma Cell LeukemiaChina
-
University of ArkansasJanssen, LPActive, not recruitingMultiple MyelomaUnited States
-
Washington University School of MedicineTerminatedMultiple MyelomaUnited States
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Australia, France, Poland, United Kingdom, Belgium, Germany, Taiwan, Spain, Israel, Japan, Canada, Netherlands, Denmark, Sweden, Korea, Republic of, Russian Federation, Greece
-
CelgeneCompleted
-
National Cancer Institute (NCI)Millennium Pharmaceuticals, Inc.Withdrawn